Article
Male breast cancer.
International journal of fertility and women's medicine - 1 Jan 2000
Joseph Antony, Mokbel Kefah
Abstract excerpt
Although male breast cancer (MBC) is rare (<1% of all BC), its reported incidence has been rising. In addition to traditional risk factors, there is now known to be a 7% life-time risk in carriers of BRCA2. This article discusses the clinical and histological presentation of MBC and reviews the main treatments.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
